Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-08-11
1982-08-31
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424316, A61K 31135
Patent
active
043472575
ABSTRACT:
A method of suppressing prolactin secretion in humans by the administration of the compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof in a non-toxic, effective prolactin suppression amount (calculated as base) to a human in need thereof.
REFERENCES:
patent: 3819706 (1974-06-01), Mehta
patent: 3885046 (1975-05-01), Mehta
Stern, W. C., et al., Life Sciences, vol. 25, pp. 1717-1724, 1979.
Brown Donald
Burroughs Wellcome Co.
Hazel Blondel
LandOfFree
Prolactin suppression in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolactin suppression in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolactin suppression in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2184234